Idenix Pharmaceuticals to Present at the 32nd Annual J.P. Morgan Healthcare
CAMBRIDGE, Mass., Jan. 7, 2014 (GLOBE NEWSWIRE) -- Idenix Pharmaceuticals,
Inc. (Nasdaq:IDIX) announced today that Idenix management will present a
corporate overview at the 32^nd Annual J.P. Morgan Healthcare Conference on
Wednesday, January 15, 2014at11:00 a.m. Pacific Timeat theWestin St.
Francis HotelinSan Francisco.
The live and archived webcast of the company presentation can be accessed
under "Events and Presentations" in the Idenix Investor Center at
www.idenix.com. Please log in approximately 5-10 minutes before the event to
ensure a timely connection. The archived replay will be available on the
Idenix website for two weeks following the conference.
Idenix Pharmaceuticals, Inc., headquartered inCambridge, Massachusetts, is a
biopharmaceutical Company engaged in the discovery and development of drugs
for the treatment of human viral diseases. Idenix's current focus is on the
treatment of patients with hepatitis C infection. For further information
about Idenix, please refer towww.idenix.com.
CONTACT: Idenix Pharmaceuticals Contact:
Idenix Pharmaceuticals logo
Press spacebar to pause and continue. Press esc to stop.